Effects of nitric oxide on platelet activation during plateletpheresis and in vivo tracking of biotinylated platelets in humans

Transfusion

Volumn 39, Issue 5, 1999, Pages 506-514

  Stohlawetz, P ^a   Horvath, M ^a   Pernerstorfer, T ^a   Nguyen, H ^a   Vondrovec, B ^a   Robisch, A ^a   Eichler, H G ^a   Spitzauer, S ^a   Jilma, Bernd ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PADGEM PROTEIN; PLACEBO; THROMBOCYTE CONCENTRATE;

ARTICLE; BIOTINYLATION; BLOOD BANK; BLOOD PRESSURE MONITORING; CELL LABELING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PHLEBOTOMY; PROTEIN EXPRESSION; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE COUNT; THROMBOCYTE LIFESPAN; THROMBOCYTE PRESERVATION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPHERESIS;

BIOTINYLATION; BLOOD PRESERVATION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; HUMANS; INFUSIONS, INTRAVENOUS; MALE; NITRIC OXIDE; NITROPRUSSIDE; PILOT PROJECTS; PLATELET ACTIVATION; PLATELET COUNT; PLATELET TRANSFUSION; PLATELETPHERESIS; REFERENCE VALUES;

EID: 0032926801     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1999.39050506.x     Document Type: Article

References (42)

1. Wallace EL, Churchill WH, Surgenor DM, et al. Collection and transfusion of blood and blood components in the United States, 1992. Transfusion 1995;35:802-12.
2. Norfolk DR, Ancliffe PJ, Contreras M, et al. Consensus conference on platelet transfusion, Royal College of Physicians of Edinburgh, 27-28 November 1997. Br J Haematol 1998;101:609-17.
3. Devine P, Goldstein R, Linden JV, et al. Data on apheresis, blood collection, and transfusion-related activities: statistical analyses of the American Association of Blood Banks institutional membership questionnaires. Transfusion 1996;36:375-81.
4. Wallace EL, Churchill WH, Surgenor DM, et al. Collection and transfusion of blood and blood components in the United States, 1994. Transfusion 1998;38:625-36.
5. Menitove JE, Snyder EL. Platelet transfusion practice: time for renewed consensus. Transfusion 1998;38:707-9.
6. Metcalfe P, Williamson LM, Reutelingsperger CP, et al. Activation during preparation of therapeutic platelets affects deterioration during storage: a comparative flow cytometric study of different production methods. Br J Haematol 1997;98:86-95.
7. Stohlawetz P, Hergovich N, Stiegler G, et al. Differential induction of P-selectin expression on platelets by two cell separators during plateletpheresis and gender effects on the release of soluble P-selectin. Transfusion 1998;38:24-30.
8. Kostelijk EH, Fijnheer R, Nieuwenhuis HK, et al. Soluble P-selectin as parameter for platelet activation during storage. Thromb Haemost 1996;76:1086-9.
9. Rinder HM, Snyder EL, Bonan JL, et al. Activation in stored platelet concentrates: correlation between membrane expression of P-selectin, glycoprotein IIb/IIIa, and β-thromboglobulin release. Transfusion 1993;33:25-9.
10. Holme S, Sweeney JD, Sawyer S, Elfath MD. The expression of p-selectin during collection, processing, and storage of platelet concentrates: relationship to loss of in vivo viability. Transfusion 1997;37:12-7.
11. Rinder HM, Murphy M, Mitchell JG, et al. Progressive platelet activation with storage: evidence for shortened survival of activated platelets after transfusion. Transfusion 1991;31:409-14.
12. Triulzi DJ, Kickler TS, Braine HG. Detection and significance of alpha granule membrane protein 140 expression on platelets collected by apheresis. Transfusion 1992;32:529-33.
13. Chernoff A, Snyder EL. The cellular and molecular basis of the platelet storage lesion: a symposium summary. Transfusion 1992;32:386-90.
14. Langford EJ, Wainwright RJ, Martin JF. Platelet activation in acute myocardial infarction and unstable angina is inhibited by nitric oxide donors. Arterioscler Thromb Vasc Biol 1996;16:51-5.
15. Harris SN, Rinder CS, Rinder HM, et al. Nitroprusside inhibition of platelet function is transient and reversible by catecholamine priming. Anesthesiology 1995;83:1145-52.
16. Murohara T, Parkinson SJ, Waldman SA, Lefer AM. Inhibition of nitric oxide biosynthesis promotes P-selectin expression in platelets. Role of protein kinase C. Arterioscler Thromb Vasc Biol 1995;15:2068-75.
17. Alberio L, Dale GL. Platelet biotinylation for monitoring in vivo survival and cellular function. Platelets 1997;8:373-8.
18. Stolley PD, Strom BL. Sample size calculations for clinical pharmacology studies. Clin Pharmacol Ther 1986;39:489-90.
19. Michimata T, Imamura M, Mizuma H, et al. Sex and age differences in soluble guanylate cyclase activity in human platelets. Life Sci 1996;58:415-9.
20. Jilma B, Eichler HG, Vondrovec B, et al. Effects of desmopressin on circulating P-selectin. Br J Haematol 1996;93:432-6.
21. Cavill I, Trevett D, Fisher J, Hoy T. The measurement of the total volume of red cells in man: a non-radioactive approach using biotin. Br J Haematol 1988;70:491-3.
22. Heilmann E, Friese P, Anderson S, et al. Biotinylated platelets: a new approach to the measurement of platelet life span. Br J Haematol 1993;85:729-35.
23. Hudson IR, Cavill IA, Cooke A, et al. Biotin labeling of red cells in the measurement of red cell volume in preterm infants. Pediatr Res 1990;28:199-202.
24. Pernerstorfer T, Stohlawetz P, Stummvoll G, et al. Low dose aspirin does not lower in vivo platelet activation in healthy smokers. Br J Haematol 1998;102:1229-31.
25. Bubel S, Wilhelm D, Entelmann M, et al. Chemokines in stored platelet concentrates. Transfusion 1996;36:445-9.
26. Michelson AD, Barnard MR, Hechtman HB, et al. In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci U S A 1996;93:11877-82.
27. Dirnberger E, Lucan H, Eichler HG, et al. Effects of nitroglycerin and sodium nitroprusside on endexpiratory concentrations of nitric oxide in healthy humans. Life Sci 1998;62:PL103-8.
28. Cordle DG, Strauss RG, Lankford G, Mock DM. Antibodies provoked by transfusion of biotin-labeled red blood cells (abstract). Transfusion 1996;36(Suppl):46S.
29. Dale GL, Gaddy P, Pikul FJ. Antibodies against biotinylated proteins are present in normal human serum. J Lab Clin Med 1994;123:365-71.
30. Stohlawetz P, Stiegler G, Jilma B, et al. Measurement of the levels of reticulated platelets after plateletpheresis to monitor activity of thrombopoiesis. Transfusion 1998;38:454-8.
31. Stohlawetz P, Seidl D, Hergovich N, et al. Safety issues of plateletpheresis: comparison of the effects of two cell separators on the activation of coagulation, flbrinolysis, and neutrophils and on the formation of white cell-platelet aggregates. Transfusion 1999;39:420-7.
32. Moroff G, Friedman A, Robkin-Kline L, et al. Reduction of the volume of stored platelet concentrates for use in neonatal patients. Transfusion 1984;24:144-6.
33. Divers SG, Kannan K, Stewart RM, et al. Quantitation of CD62, soluble CD62, and lysosome-associated membrane proteins 1 and 2 for evaluation of the quality of stored platelet concentrates. Transfusion 1995;35:292-7.
34. Snyder EL. Activation during preparation and storage of platelet concentrates. Transfusion 1992;32:500-2.
35. Alcorta I, Pereira A, Ordinas A. Clinical and laboratory factors associated with platelet transfusion refractoriness: a case-control study. Br J Haematol 1996;93:220-4.
36. Jilma B, Hergovich N, Stohlawetz P, et al. Effects of sodium nitroprusside on hemodialysis-induced platelet activation. Kidney Int 1995;55:686-91.
37. Langford EJ, Parfitt A, deBelder AJ, et al. A study of platelet activation during human cardiopulmonary bypass and the effect of S-nitrosoglutathione. Thromb Haemost 1997;78:1516-9.
38. Franco RS, Lee KN, Barker Gear R, et al. Use of bi-level biotinylation for concurrent measurement of in vivo recovery and survival in two rabbit platelet populations. Transfusion 1994;34:784-9.
39. Magnusson S, Hou M, Hallberg E, et al. Biotinylated platelets have an impaired response to agonists as evidenced by in vitro platelet aggregation tests (abstract). Thromb Res 1998;89:53-8.
40. Snyder EL. Effects of storage conditions on radiolabeling of stored platelet concentrates. Transfusion 1986;26:6-8.
41. 111indium-labeled human platelets. Br J Haematol 1980;44:269-80.
42. Harker LA, Roskos L, Cheung E. Effective and efficient platelet transfusion strategies that maintain hemostatic protection. Transfusion 1998;38:619-21.